Stockhouse The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about ... and more »
FRONTLINE The biology is very difficult to develop completely novel chemical entities that aren't part of existing chemical series like, say, the carbapenems and just optimize your molecules. That's fine; that's the easiest way to go. But to come up with a ...
Healio They assessed for treatment with broad-spectrum antimicrobials — third-generation cephalosporins with or without macrolide — and narrow-spectrum antimicrobials — aminopenicillins with or without macrolide — within the first 2 days of hospital stay.
separationsNOW.com Biomedical Chromatography, 2013, 27, 1243-1258. Kuldeep Sharma, Ramesh Mullangi. Abstract: Azithromycin is one of the best selling antibiotics in the world. It belongs to the new macrolide family of azalides. It is derived from erythromycin and it ...
GlobeNewswire (press release) The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about ... and more »
News-Medical.net ... the world, but again seems to reduce exacerbations in people with COPD. Those are our main therapies. There is some discussion about mucolytic agents, some discussion about theophylline, and also macrolide antibiotics. But it's all relatively unproven.
Healio They assessed for treatment with broad-spectrum antimicrobials — third-generation cephalosporins with or without macrolide — and narrow-spectrum antimicrobials — aminopenicillins with or without macrolide — within the first 2 days of hospital stay.
Healio They assessed for treatment with broad-spectrum antimicrobials — third-generation cephalosporins with or without macrolide — and narrow-spectrum antimicrobials — aminopenicillins with or without macrolide — within the first 2 days of hospital stay.
Healio They assessed for treatment with broad-spectrum antimicrobials — third-generation cephalosporins with or without macrolide — and narrow-spectrum antimicrobials — aminopenicillins with or without macrolide — within the first 2 days of hospital stay.